Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.
Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel AN, Scheijmans LJ, van der Sangen MJ, Botke G, Hoekstra CJ, Jobsen JJ, van de Velde CJ, von Meyenfeldt MF, Tabak JM, Peterse JL, van de Vijver MJ, Coebergh JW, van Tienhoven G; Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group). Voogd AC, et al. Among authors: scheijmans lj. Eur J Cancer. 2005 Nov;41(17):2637-44. doi: 10.1016/j.ejca.2005.04.040. Epub 2005 Aug 22. Eur J Cancer. 2005. PMID: 16115758
Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial.
Kimman ML, Dirksen CD, Voogd AC, Falger P, Gijsen BC, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, Hupperets P, Nuytinck JK, van Riet Y, Brenninkmeijer SJ, Scheijmans LJ, Kessels A, Lambin P, Boersma LJ. Kimman ML, et al. Among authors: scheijmans lj. Eur J Cancer. 2011 May;47(7):1027-36. doi: 10.1016/j.ejca.2010.12.003. Epub 2011 Jan 13. Eur J Cancer. 2011. PMID: 21237636 Clinical Trial.
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT.
Kimman ML, Dirksen CD, Voogd AC, Falger P, Gijsen BC, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, Hupperets P, Nuytinck JK, van Riet Y, Brenninkmeijer SJ, Scheijmans LJ, Kessels A, Lambin P, Boersma LJ. Kimman ML, et al. Among authors: scheijmans lj. Eur J Cancer. 2011 May;47(8):1175-85. doi: 10.1016/j.ejca.2010.12.017. Epub 2011 Jan 21. Eur J Cancer. 2011. PMID: 21257305 Clinical Trial.
Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.
Brouwers PJAM, van Werkhoven E, Bartelink H, Fourquet A, Lemanski C, van Loon J, Maduro JH, Russell NS, Scheijmans LJEE, Schinagl DAX, Westenberg AH, Poortmans P, Boersma LJ; Young Boost Trial research group. Brouwers PJAM, et al. Among authors: scheijmans ljee. Radiother Oncol. 2018 Sep;128(3):434-441. doi: 10.1016/j.radonc.2018.06.020. Epub 2018 Jul 3. Radiother Oncol. 2018. PMID: 29980320 Clinical Trial.
[Usefulness of treatment of low-grade glioma controversial].
Struikmans H, Scheijmans LJ, Rutgers DH. Struikmans H, et al. Among authors: scheijmans lj. Ned Tijdschr Geneeskd. 1994 Jul 30;138(31):1588-9. Ned Tijdschr Geneeskd. 1994. PMID: 8072577 Dutch. No abstract available.
Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.
Brouwers PJ, van Werkhoven E, Bartelink H, Fourquet A, Lemanski C, van Loon J, Maduro JH, Russell NS, Scheijmans LJ, Schinagl DA, Westenberg AH, Poortmans P, Boersma LJ; Young Boost Trial research group. Brouwers PJ, et al. Among authors: scheijmans lj. Radiother Oncol. 2016 Jul;120(1):107-13. doi: 10.1016/j.radonc.2016.04.017. Epub 2016 May 28. Radiother Oncol. 2016. PMID: 27247055 Clinical Trial.
12 results